Parkman Healthcare Partners as of Dec. 31, 2024
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 89 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 4.6 | $35M | 375k | 92.37 | |
| Verona Pharma Sponsored Ads (VRNA) | 4.5 | $34M | 721k | 46.44 | |
| Insulet Corporation (PODD) | 4.4 | $33M | 126k | 261.07 | |
| Boston Scientific Corporation (BSX) | 4.0 | $30M | 337k | 89.32 | |
| Stryker Corporation (SYK) | 3.7 | $28M | 78k | 360.05 | |
| Cooper Cos (COO) | 3.4 | $25M | 275k | 91.93 | |
| Eli Lilly & Co. (LLY) | 2.9 | $22M | 28k | 772.00 | |
| Miragen Therapeutics (VRDN) | 2.8 | $21M | 1.1M | 19.17 | |
| Intra Cellular Therapies (ITCI) | 2.7 | $20M | 243k | 83.52 | |
| Mannkind Corp Com New (MNKD) | 2.7 | $20M | 3.1M | 6.43 | |
| Abbott Laboratories (ABT) | 2.7 | $20M | 177k | 113.11 | |
| Travere Therapeutics (TVTX) | 2.6 | $20M | 1.1M | 17.42 | |
| Arcus Biosciences Incorporated (RCUS) | 2.5 | $19M | 1.3M | 14.89 | |
| Becton, Dickinson and (BDX) | 2.1 | $16M | 70k | 226.87 | |
| Neurocrine Biosciences (NBIX) | 2.1 | $16M | 116k | 136.50 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 2.0 | $15M | 766k | 19.78 | |
| Quest Diagnostics Incorporated (DGX) | 1.8 | $14M | 90k | 150.86 | |
| Tenet Healthcare Corp Com New (THC) | 1.8 | $14M | 107k | 126.23 | |
| United Therapeutics Corporation (UTHR) | 1.8 | $13M | 38k | 352.84 | |
| McKesson Corporation (MCK) | 1.7 | $13M | 23k | 569.91 | |
| Day One Biopharmaceuticals I (DAWN) | 1.7 | $13M | 1.0M | 12.67 | |
| Qiagen Nv Shs New | 1.6 | $12M | 277k | 44.53 | |
| CVRX (CVRX) | 1.6 | $12M | 921k | 12.67 | |
| Schrodinger (SDGR) | 1.4 | $11M | 563k | 19.29 | |
| Edwards Lifesciences (EW) | 1.4 | $11M | 145k | 74.03 | |
| Replimune Group (REPL) | 1.4 | $11M | 870k | 12.11 | |
| Rxsight (RXST) | 1.4 | $10M | 301k | 34.38 | |
| Edgewise Therapeutics (EWTX) | 1.4 | $10M | 381k | 26.70 | |
| UnitedHealth (UNH) | 1.3 | $10M | 20k | 505.86 | |
| Nurix Therapeutics (NRIX) | 1.3 | $10M | 532k | 18.84 | |
| Vaxcyte (PCVX) | 1.3 | $9.5M | 116k | 81.86 | |
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $9.1M | 39k | 235.31 | |
| Castle Biosciences (CSTL) | 1.1 | $8.1M | 305k | 26.65 | |
| Livanova SHS (LIVN) | 1.1 | $8.1M | 175k | 46.31 | |
| CVS Caremark Corporation (CVS) | 1.1 | $8.1M | 180k | 44.89 | |
| Ptc Therapeutics I (PTCT) | 1.1 | $8.0M | 177k | 45.14 | |
| Quidel Corp (QDEL) | 1.0 | $7.8M | 175k | 44.55 | |
| Xenon Pharmaceuticals (XENE) | 1.0 | $7.6M | 193k | 39.20 | |
| Amicus Therapeutics (FOLD) | 1.0 | $7.4M | 784k | 9.42 | |
| Syndax Pharmaceuticals (SNDX) | 0.9 | $7.0M | 527k | 13.22 | |
| Dex (DXCM) | 0.8 | $6.1M | 79k | 77.77 | |
| Axogen (AXGN) | 0.8 | $6.0M | 366k | 16.48 | |
| Keros Therapeutics (KROS) | 0.7 | $5.0M | 315k | 15.83 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.7 | $4.9M | 353k | 14.00 | |
| Uniqure Nv SHS (QURE) | 0.6 | $4.9M | 275k | 17.66 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.6 | $4.6M | 38k | 123.15 | |
| Terns Pharmaceuticals (TERN) | 0.6 | $4.6M | 829k | 5.54 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.6 | $4.3M | 197k | 22.04 | |
| Ultragenyx Pharmaceutical (RARE) | 0.6 | $4.2M | 100k | 42.07 | |
| Veracyte (VCYT) | 0.5 | $4.0M | 100k | 39.60 | |
| Inari Medical Ord | 0.5 | $3.9M | 77k | 51.05 | |
| Urogen Pharma (URGN) | 0.5 | $3.9M | 370k | 10.65 | |
| Apogee Therapeutics (APGE) | 0.5 | $3.9M | 85k | 45.30 | |
| Performant Finl (PHLT) | 0.5 | $3.8M | 1.3M | 3.02 | |
| Eton Pharmaceuticals (ETON) | 0.5 | $3.7M | 277k | 13.32 | |
| Arcellx Common Stock (ACLX) | 0.5 | $3.4M | 45k | 76.69 | |
| Silence Therapeutics Ads (SLN) | 0.4 | $3.4M | 491k | 6.88 | |
| Icon SHS (ICLR) | 0.4 | $3.3M | 16k | 209.71 | |
| Sutro Biopharma (STRO) | 0.4 | $3.2M | 1.7M | 1.84 | |
| Mbx Biosciences (MBX) | 0.4 | $3.1M | 170k | 18.43 | |
| Si-bone (SIBN) | 0.4 | $3.0M | 217k | 14.02 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.4 | $2.9M | 54k | 54.15 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.4 | $2.8M | 221k | 12.77 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.3 | $2.6M | 51k | 51.13 | |
| Insmed Com Par $.01 (INSM) | 0.3 | $2.5M | 36k | 69.04 | |
| Butterfly Network Com Cl A (BFLY) | 0.3 | $2.3M | 750k | 3.12 | |
| Inspiremd (NSPR) | 0.3 | $2.2M | 855k | 2.63 | |
| Alphatec Hldgs Com New (ATEC) | 0.3 | $2.1M | 228k | 9.18 | |
| Relay Therapeutics (RLAY) | 0.3 | $2.1M | 501k | 4.12 | |
| Arvinas Ord (ARVN) | 0.3 | $2.0M | 107k | 19.17 | |
| Lifestance Health Group (LFST) | 0.3 | $2.0M | 278k | 7.37 | |
| Xeris Pharmaceuticals (XERS) | 0.3 | $2.0M | 579k | 3.39 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.3 | $2.0M | 76k | 25.70 | |
| Merus N V (MRUS) | 0.3 | $1.9M | 46k | 42.05 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.3 | $1.9M | 350k | 5.45 | |
| Nuvalent Inc-a (NUVL) | 0.2 | $1.8M | 24k | 78.28 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.2 | $1.8M | 409k | 4.43 | |
| Annexon (ANNX) | 0.2 | $1.7M | 331k | 5.13 | |
| Oscar Health Cl A (OSCR) | 0.2 | $1.7M | 125k | 13.44 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $1.6M | 217k | 7.52 | |
| Pulmonx Corp (LUNG) | 0.2 | $1.4M | 208k | 6.79 | |
| Reviva Pharmaceutcls Hldgs I (RVPH) | 0.1 | $931k | 514k | 1.81 | |
| Ardelyx (ARDX) | 0.1 | $901k | 178k | 5.07 | |
| Third Harmonic Bio (THRD) | 0.1 | $892k | 87k | 10.29 | |
| Entera Bio SHS (ENTX) | 0.1 | $877k | 414k | 2.12 | |
| Ceribell (CBLL) | 0.1 | $828k | 32k | 25.88 | |
| Eliem Therapeutics (CLYM) | 0.1 | $523k | 291k | 1.80 | |
| Vyne Therapeutics (VYNE) | 0.1 | $513k | 153k | 3.35 | |
| Edap Tms S A Sponsored Adr (EDAP) | 0.0 | $342k | 155k | 2.21 |
